Compare PCVX & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | NOV |
|---|---|---|
| Founded | 2013 | 1862 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.6B |
| IPO Year | 2020 | 1996 |
| Metric | PCVX | NOV |
|---|---|---|
| Price | $53.94 | $18.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | ★ $98.33 | $18.00 |
| AVG Volume (30 Days) | 1.1M | ★ 4.0M |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $8,744,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.04 |
| P/E Ratio | ★ N/A | $46.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.09 | $10.84 |
| 52 Week High | $76.61 | $20.77 |
| Indicator | PCVX | NOV |
|---|---|---|
| Relative Strength Index (RSI) | 41.19 | 44.68 |
| Support Level | $42.30 | $17.70 |
| Resistance Level | $56.04 | $19.22 |
| Average True Range (ATR) | 2.45 | 0.62 |
| MACD | -0.89 | -0.18 |
| Stochastic Oscillator | 7.47 | 22.11 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
NOV designs, manufactures, and sells a wide range of equipment and components supplying the oil and gas industry, including rig equipment, downhole tools, drill pipe, and well casing. NOV's customers include major integrated oil companies, national oil companies, independent oil and gas companies, and drilling contractors. Its operations are organized into two reportable segments: energy products and services and energy equipment. NOV operates on a global scale, with international markets contributing nearly two-thirds of its annual revenue.